Phase 2, open-label, noncomparative clinical trial evaluating safety and efficacy of posaconazole in pediatric patients with proven/probable invasive aspergillosis or possible invasive fungal disease. (journals.asm.org)

Authors: Kang HJ … Johnson MG Journal: Antimicrobial Agents and Chemotherapy Published: 2026-03-04 DOI: https://doi.org/10.1128/aac.01305-25